18.212.120.195
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Oculoplastics-ASOPRS
Baseline imaging may predict teprotumumab response
TED may result in changes across the entire face
Coupled medical and surgical treatment needed for TED
POLL: Do you believe all TED is inflammatory/active?
Usher Syndrome: A Physician Perspective
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
OSD / Dry Eye
November 22, 2021

Integrating lifestyle changes with customized medical care is imperative for success. By Laura M. Periman, MD When we consider the updated definition of dry eye disease (DED) from 2017 TFOS DEWS II, we...

-Advertisement-
-Advertisement-
-Advertisement-
Glaucoma
November 16, 2021

A study compared the iStent Inject, Kahook Dual Blade (KDB), Trabectome, and Hydrus Microstent and found KDB to be most cost-effective in terms of cost per mmHG of IOP reduction.

-Advertisement-
-Advertisement-
-Advertisement-

Polls & Quizzes

POLL: Do you believe all TED is inflammatory/active?
Dec 01, 2021

Podcasts

David Pyott and Jim Mazzo talk newly formed Ophthalmology Foundation
Apr 20, 2021

Quizzes

QUIZ: Understanding the Natural History of TED
Nov 29, 2021

Videos

Usher Syndrome: A Physician Perspective
Nov 30, 2021
Oculoplastics
December 2, 2021

Total rectus volume is predictive of proptosis reduction following treatment with teprotumumab in patients with thyroid eye disease (TED), according to a study that examined potentially predictive baseline imaging characteristics. Of the 25...

-Advertisement-
-Advertisement-
-Advertisement-
Pediatrics
October 20, 2021

The U.S. Food and Drug Administration has approved Luminopia One (Luminopia) as a prescription therapy to improve vision in children with amblyopia (lazy eye), the leading cause of vision loss in children, according...

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-